Key clinical summary
The strongest decision-making comes from matching product choice to diagnosis, expectation and pathway stage—not from assuming newer always means better.
- Both are selected osteoarthritis options, usually after first-line rehab has already been used.
- Evidence quality and clinical experience differ between products.
- Neither replaces strength work, pacing and realistic counselling.
Arthrosamid and hyaluronic acid are both discussed in selected knee osteoarthritis pathways, but they are not interchangeable simply because both are injections. The comparison should focus on what the patient is hoping to achieve, what the evidence supports, and how either option fits into the wider care plan.
How the options are commonly framed
Hyaluronic acid is a more established viscosupplement-style option with mixed but usable evidence in selected knee OA. Arthrosamid is a newer hydrogel pathway presented as a longer-horizon symptom and function option for carefully selected patients.
Where selection matters most
A patient who needs rapid inflammatory calm-down may actually suit neither option as well as steroid. A patient with selected knee OA who has engaged with rehab and wants a non-steroid procedural option may be a more logical candidate for discussion.
What the consultation should avoid
Premium practice avoids overselling innovation. Both procedures require honest explanation of uncertainty, likely timelines and the ongoing role of exercise and weight-bearing progression.
How to compare them practically
The decision often turns on previous treatment response, willingness to wait for gradual improvement, budget considerations, and the clinician's judgement about which option is most defensible for that individual knee.
Evidence strength summary
Evidence for hyaluronic acid is mixed but broader, while evidence for Arthrosamid is newer and still evolving. Both require careful selection and expectation setting rather than product-first marketing.
How the evidence is used
Page-specific FAQs
Which has the stronger evidence base right now?
Hyaluronic acid has a longer evidence history; Arthrosamid has newer emerging data.
Which works faster?
Both are usually discussed as gradual rather than immediate options.
Can I choose either without doing physiotherapy?
That would usually be a weaker pathway.
Why would a clinician recommend one over the other?
Because the selection is based on the individual knee, previous response and realistic goals.
Do both need ultrasound guidance?
Guidance is helpful when accurate intra-articular placement is important.
Harvard references
- Conaghan, P.G. et al. (2018) A multicentre, randomised trial of a single intra-articular injection of non-animal stabilised hyaluronic acid in knee osteoarthritis. Osteoarthritis and Cartilage, 26(8), pp.1050–1057.
- Bliddal, H. et al. (2024) Effectiveness and safety of polyacrylamide hydrogel injection for knee osteoarthritis. Therapeutic Advances in Musculoskeletal Disease, 16, 1–13.
- Bannuru, R.R. et al. (2019) OARSI guidelines for the non-surgical management of knee, hip and polyarticular osteoarthritis. Osteoarthritis and Cartilage, 27(11), pp.1578–1589.
- Kolasinski, S.L. et al. (2020) 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis. Arthritis Care & Research, 72(2), pp.149–162.
- Daniels, E.W. et al. (2018) Accuracy of ultrasound-guided versus landmark-guided intra-articular injection. PM&R, 10(8), pp.847–856.
- Sibbitt, W.L. et al. (2011) Does sonographic needle guidance affect injection outcome? Journal of Rheumatology, 38(2), pp.340–347.
Most patients choose a same-visit diagnostic pathway
For suitable cases we can assess, explain the likely diagnosis, use ultrasound where it adds value, and discuss whether rehabilitation alone or rehabilitation plus a guided injection is the most sensible next step.